Proposed Vaccine Information Materials for Measles, Mumps, Rubella, and Varicella Vaccines, 48715-48719 [2010-19785]

Download as PDF Federal Register / Vol. 75, No. 154 / Wednesday, August 11, 2010 / Notices vaccination. People with a mild illness can usually get the vaccine. sroberts on DSKD5P82C1PROD with NOTICES 5. When should I get influenza vaccine? You can get the vaccine as soon as it is available, usually in the fall, and for as long as illness is occurring in your community. Influenza can occur any time, but most influenza occurs from November through May. In most seasons, most infections occur in January and February. Getting vaccinated in December, or even later, will still be beneficial in most years. Adults and older children need one dose of influenza vaccine each year. But some children younger than 9 years of age need 2 doses to be protected. Ask your provider. Influenza vaccine may be given at the same time as other vaccines. 6. What are the risks from LAIV? A vaccine, like any medicine, could possibly cause serious problems, such as severe allergic reactions. The risk of a vaccine causing serious harm, or death, is extremely small. Live influenza vaccine viruses very rarely spread from person to person. Even if they do, they are not likely to cause illness. LAIV is made from weakened virus and does not cause influenza. The vaccine can cause mild symptoms in people who get it (see below). Mild problems: Some children and adolescents 2–17 years of age have reported mild reactions, including: • Runny nose, nasal congestion or cough • Fever • Headache and muscle aches • Wheezing • Abdominal pain or occasional vomiting or diarrhea Some adults 18–49 years of age have reported: • Runny nose or nasal congestion • Sore throat • Cough, chills, tiredness/weakness • Headache Severe problems: • Life-threatening allergic reactions from vaccines are very rare. If they do occur, it is usually within a few minutes to a few hours after the vaccination. • If rare reactions occur with any product, they may not be identified until thousands, or millions, of people have used it. Millions of doses of LAIV have been distributed since it was licensed, and no serious problems have been identified. Like all vaccines, LAIV will continue to be monitored for unusual or severe problems. Any unusual condition, such as a high fever or behavior changes. Signs of a severe allergic reaction can include difficulty breathing, hoarseness or wheezing, hives, paleness, weakness, a fast heart beat or dizziness. What should I do? • Call a doctor, or get the person to a doctor right away. • Tell the doctor what happened, the date and time it happened, and when the vaccination was given. • Ask your provider to report the reaction by filing a Vaccine Adverse Event Reporting System (VAERS) form. Or you can file this report through the VAERS Web site at www.vaers.hhs.gov, or by calling 1–800–822–7967. VAERS does not provide medical advice. 8. The National Vaccine Injury Compensation Program The National Vaccine Injury Compensation Program (VICP) was created in 1986. Persons who believe they may have been injured by a vaccine can learn about the program and about filing a claim by calling 1–800–338–2382, or visiting the VICP Web site at www.hrsa.gov/vaccinecompensation. 9. How can I learn more? • Ask your provider. They can give you the vaccine package insert or suggest other sources of information. • Call your local or state health department. • Contact the Centers for Disease Control and Prevention (CDC): —Call 1–800–232–4636 (1–800–CDC– INFO) or —Visit CDC’s Web site at www.cdc.gov/ flu. Department of Health and Human Services, Centers for Disease Control and Prevention, Vaccine Information Statement, Live, Attenuated Influenza Vaccine, (00/00/0000) (Proposed) 42 U.S.C. 300aa–26. Dated: August 3, 2010. Tanja Popovic, Deputy Associate Director for Science, Centers for Disease Control and Prevention. [FR Doc. 2010–19788 Filed 8–10–10; 8:45 am] BILLING CODE 4163–18–P 7. What if there is a severe reaction? What should I look for? VerDate Mar<15>2010 16:52 Aug 10, 2010 Jkt 220001 PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 48715 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Proposed Vaccine Information Materials for Measles, Mumps, Rubella, and Varicella Vaccines Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: Under the National Childhood Vaccine Injury Act (NCVIA) (42 U.S.C. 300aa–26), the CDC must develop vaccine information materials that all health care providers are required to give to patients/parents prior to administration of specific vaccines. CDC seeks written comment on proposed new vaccine information materials for measles, mumps rubella (MMR); varicella, and measles, mumps, rubella; and varicella (MMRV). DATES: Written comments are invited and must be received on or before October 12, 2010. ADDRESSES: Written comments should be addressed to Anne Schuchat, M.D., Director, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Mailstop E–05, 1600 Clifton Road, NE., Atlanta, Georgia 30333. FOR FURTHER INFORMATION CONTACT: Skip Wolfe, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Mailstop E–52, 1600 Clifton Road, NE., Atlanta, Georgia 30333, telephone (404) 639–8809. SUPPLEMENTARY INFORMATION: The National Childhood Vaccine Injury Act of 1986 (Pub L. 99–660), as amended by section 708 of Public Law 103–183, added section 2126 to the Public Health Service Act. Section 2126, codified at 42 U.S.C. 300aa–26, requires the Secretary of Health and Human Services to develop and disseminate vaccine information materials for distribution by all health care providers in the United States to any patient (or to the parent or legal representative in the case of a child) receiving vaccines covered under the National Vaccine Injury Compensation Program. Development and revision of the vaccine information materials, also known as Vaccine Information Statements (VIS), have been delegated by the Secretary to the Centers for Disease Control and Prevention (CDC). Section 2126 requires that the materials be developed, or revised, after notice to the public, with a 60-day comment SUMMARY: E:\FR\FM\11AUN1.SGM 11AUN1 48716 Federal Register / Vol. 75, No. 154 / Wednesday, August 11, 2010 / Notices sroberts on DSKD5P82C1PROD with NOTICES period, and in consultation with the Advisory Commission on Childhood Vaccines, appropriate health care provider and parent organizations, and the Food and Drug Administration. The law also requires that the information contained in the materials be based on available data and information, be presented in understandable terms, and include: (1) A concise description of the benefits of the vaccine, (2) A concise description of the risks associated with the vaccine, (3) A statement of the availability of the National Vaccine Injury Compensation Program, and (4) Such other relevant information as may be determined by the Secretary. The vaccines initially covered under the National Vaccine Injury Compensation Program were diphtheria, tetanus, pertussis, measles, mumps, rubella and poliomyelitis vaccines. Since April 15, 1992, any health care provider in the United States who intends to administer one of these covered vaccines is required to provide copies of the relevant vaccine information materials prior to administration of any of these vaccines. Since then, the following vaccines have been added to the National Vaccine Injury Compensation Program, requiring use of vaccine information materials for them as well: Hepatitis B, haemophilus influenzae type b (Hib), varicella (chickenpox), pneumococcal conjugate, rotavirus, hepatitis A, meningococcal, human papillomavirus (HPV), and trivalent influenza vaccines. Instructions for use of the vaccine information materials and copies of the materials can be found on the CDC Web site at: https://www.cdc.gov/vaccines/ pubs/VIS/. In addition, single cameraready copies may be available from State health departments. A list of State health department contacts for obtaining copies of these materials is included in a December 17, 1999 Federal Register notice (64 FR 70914). Proposed Measles, Mumps, Rubella (MMR); Varicella; and Measles, Mumps, Rubella & Varicella (MMRV) Vaccine Information Materials On May 7, 2010 the Advisory Committee on Immunization Practices (ACIP) published recommendations on the use of combined Measles, Mumps, Rubella and Varicella (MMRV) vaccine. Because CDC/ACIP are now expressing a preference for use of MMRV vaccine (over MMR + V given separately) in some circumstances and the two separate vaccines in other circumstances, CDC is proposing publication of unique vaccine VerDate Mar<15>2010 16:52 Aug 10, 2010 Jkt 220001 information materials for MMRV vaccine, which are included in this notice. In addition, CDC is proposing updated versions of the separate MMR and varicella vaccine information materials, containing information about MMRV vaccine. Development of Vaccine Information Materials The vaccine information materials referenced in this notice are being developed in consultation with the Advisory Commission on Childhood Vaccines, the Food and Drug Administration, and parent and health care provider groups. In addition, we invite written comment on the proposed vaccine information materials that follow, entitled ‘‘Measles, Mumps, Rubella (MMR) Vaccine: What You Need to Know;’’ ‘‘Varicella Vaccine: What You Need to Know;’’ and ‘‘Measles, Mumps, Rubella and Varicella (MMRV) Vaccine: What You Need to Know.’’ Comments submitted will be considered in finalizing these materials. When the final materials are published in the Federal Register, the notice will include an effective date for their mandatory use. We also propose to revise the June 9, 2010 Instructions for the Use of Vaccine Information Statements to include a reference to these vaccine information materials. * * * * * Proposed MMR Vaccine Information Statement miscarriage or her baby could be born with serious birth defects. You or your child could catch these diseases by being around someone who has them. They spread from person to person through the air. Measles, mumps, and rubella (MMR) vaccine can prevent these diseases. Most children who get their MMR shots will not get these diseases. Many more children would get them if we stopped vaccinating. 2. Who should get MMR vaccine and when? Children should get 2 doses of MMR vaccine: —The first at 12–15 months of age —and the second at 4–6 years of age. These are the recommended ages. But children can get the second dose at any age, as long as it is at least 28 days after the first dose. Some adults should also get MMR vaccine: Generally, anyone 18 years of age or older who was born after 1956 should get at least one dose of MMR vaccine, unless they can show that they have had either the vaccines or the diseases. Ask your provider for more information. MMR vaccine may be given at the same time as other vaccines. Note: Children 12 years of age and younger can receive a ‘‘combination’’ vaccine called MMRV, which contains both MMR and varicella (chickenpox) vaccines. See the MMRV Vaccine Information Statement for more information. Measles, Mumps and Rubella (MMR) Vaccines: What You Need to Know 3. Some People Should Not Get MMR Vaccine or Should Wait 1. Why get vaccinated? • People should not get MMR vaccine who have ever had a life-threatening allergic reaction to gelatin, the antibiotic neomycin, or to a previous dose of MMR vaccine. • People who are moderately or severely ill at the time the shot is scheduled should usually wait until they recover before getting MMR vaccine. • Pregnant women should wait to get MMR vaccine until after they have given birth. Women should avoid getting pregnant for 4 weeks after getting MMR vaccine. • Some people should check with their doctor about whether they should get MMR vaccine, including anyone who: —Has HIV/AIDS, or another disease that affects the immune system. —Is being treated with drugs that affect the immune system, such as steroids, for 2 weeks or longer. —Has any kind of cancer. Measles, mumps, and rubella are serious diseases. Measles • Measles virus causes rash, cough, runny nose, eye irritation, and fever. • It can lead to ear infection, pneumonia, seizures (jerking and staring), brain damage, and death. Mumps • Mumps virus causes fever, headache, and swollen glands. • It can lead to deafness, meningitis (infection of the brain and spinal cord covering), painful swelling of the testicles or ovaries, and rarely sterility or death. Rubella (German Measles) • Rubella virus causes rash, mild fever, and arthritis (mostly in women). • If a woman gets rubella while she is pregnant, she could have a PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 E:\FR\FM\11AUN1.SGM 11AUN1 Federal Register / Vol. 75, No. 154 / Wednesday, August 11, 2010 / Notices —Is taking cancer treatment with x-rays or drugs. —Has ever had a low platelet count (a blood disorder). • People who recently had a transfusion or were given other blood products should ask their doctor when they may get MMR vaccine. Ask your provider for more information. 4. What are the risks from MMR vaccine? A vaccine, like any medicine, is capable of causing serious problems, such as severe allergic reactions. The risk of MMR vaccine causing serious harm, or death, is extremely small. Getting MMR vaccine is much safer than getting any of these three diseases. Most people who get MMR vaccine do not have any problems with it. Mild Problems • Fever (up to 1 person out of 6) • Mild rash (about 1 person out of 20) • Swelling of glands in the cheeks or neck (rare) If these problems occur, it is usually within 7–12 days after the shot. They occur less often after the second dose. Moderate Problems • Seizure (jerking or staring) caused by fever (about 1 out of 3,000 doses) • Temporary pain and stiffness in the joints, mostly in teenage or adult women (up to 1 out of 4) • Temporary low platelet count, which can cause a bleeding disorder (about 1 out of 30,000 doses) sroberts on DSKD5P82C1PROD with NOTICES Severe Problems (Very Rare) • Serious allergic reaction (less than 1 out of a million doses). • Several other severe problems have been known to occur after a child gets MMR vaccine. But this happens so rarely, experts cannot be sure whether they are caused by the vaccine or not. These include: —Deafness, —Long-term seizures, coma, or lowered consciousness, —Permanent brain damage. Note: The first dose of MMRV vaccine has been associated with rash and higher rates of fever than MMR and varicella vaccines given separately. Rash has been reported in about 1 person in 20 and fever in about 1 person in 5. Seizures caused by a fever are also reported more often after MMRV. These usually occur 5–12 days after the first dose. 5. What if there is a severe or moderate reaction? What should I look for? Any unusual condition, such as a high fever or behavior changes. Signs of VerDate Mar<15>2010 16:52 Aug 10, 2010 Jkt 220001 a severe allergic reaction can include difficulty breathing, hoarseness or wheezing, hives, paleness, weakness, a fast heart beat or dizziness. What should I do? • Call a doctor, or get the person to a doctor right away. • Tell the doctor what happened, the date and time it happened, and when the vaccination was given. • Ask your provider to report the reaction by filing a Vaccine Adverse Event Reporting System (VAERS) form. Or you can file this report through the VAERS Web site at https:// www.vaers.hhs.gov, or by calling 1–800–822–7967. VAERS does not provide medical advice. 6. The National Vaccine Injury Compensation Program The National Vaccine Injury Compensation Program (VICP) was created in 1986. Persons who believe they may have been injured by a vaccine may file a claim with VICP by calling 1–800–338– 2382 or visiting their Web site at https://www.hrsa.gov/ vaccinecompensation. 7. How can I learn more? • Ask your provider. They can give you the vaccine package insert or suggest other sources of information. • Call your local or state health department. • Contact the Centers for Disease Control and Prevention (CDC): —Call 1–800–232–4636 (1–800–CDC– INFO) —Visit CDC’s Web site at https:// www.cdc.gov/vaccines Department of Health and Human Services Centers for Disease Control and Prevention Vaccine Information Statement MMR Vaccine (00/00/0000) (Proposed) 42 U.S.C. 300aa–26 * * * * * Proposed Varicella (Chickenpox) Vaccine Information Statement Chickenpox Vaccine: What You Need to Know 1. Why get vaccinated? Chickenpox (also called varicella) is a common childhood disease. It is usually mild, but it can be serious, especially in young infants and adults. • It causes a rash, itching, fever, and tiredness. • It can lead to severe skin infection, scars, pneumonia, brain damage, or death. PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 48717 • The chickenpox virus can be spread from person to person through the air, or by contact with fluid from chickenpox blisters. • A person who has had chickenpox can get a painful rash called shingles years later. • Before the vaccine, about 11,000 people were hospitalized for chickenpox each year in the United States. • Before the vaccine, about 100 people died each year as a result of chickenpox in the United States. Chickenpox vaccine can prevent chickenpox. Most people who get chickenpox vaccine will not get chickenpox. But if someone who has been vaccinated does get chickenpox, it is usually very mild. They will have fewer blisters, are less likely to have a fever, and will recover faster. 2. Who should get chickenpox vaccine and when? Routine Children who have never had chickenpox should get 2 doses of chickenpox vaccine at these ages: 1st Dose: 12–15 months of age 2nd Dose: 4–6 years of age (may be given earlier, if at least 3 months after the 1st dose) People 13 years of age and older (who have never had chickenpox or received chickenpox vaccine) should get two doses at least 28 days apart. Catch-Up Anyone who is not fully vaccinated, and never had chickenpox, should receive one or two doses of chickenpox vaccine. The timing of these doses depends on the person’s age. Ask your provider. Chickenpox vaccine may be given at the same time as other vaccines. Note: Children 12 years of age and younger can receive a ‘‘combination’’ vaccine called MMRV, which contains both MMR and varicella (chickenpox) vaccines. See the MMRV Vaccine Information Statement for more information. 3. Some People Should Not Get Chickenpox Vaccine or Should Wait • People should not get chickenpox vaccine if they have ever had a lifethreatening allergic reaction to a previous dose of chickenpox vaccine or to gelatin or the antibiotic neomycin. • People who are moderately or severely ill at the time the shot is scheduled should usually wait until they recover before getting chickenpox vaccine. • Pregnant women should wait to get chickenpox vaccine until after they have E:\FR\FM\11AUN1.SGM 11AUN1 48718 Federal Register / Vol. 75, No. 154 / Wednesday, August 11, 2010 / Notices given birth. Women should not get pregnant for 1 month after getting chickenpox vaccine. • Some people should check with their doctor about whether they should get chickenpox vaccine, including anyone who: —Has HIV/AIDS or another disease that affects the immune system —Is being treated with drugs that affect the immune system, such as steroids, for 2 weeks or longer —Has any kind of cancer —Is getting cancer treatment with radiation or drugs • People who recently had a transfusion or were given other blood products should ask their doctor when they may get chickenpox vaccine. Ask your provider for more information. 4. What are the risks from chickenpox vaccine? A vaccine, like any medicine, is capable of causing serious problems, such as severe allergic reactions. The risk of chickenpox vaccine causing serious harm, or death, is extremely small. Getting chickenpox vaccine is much safer than getting chickenpox disease. Most people who get chickenpox vaccine do not have any problems with it. Reactions are usually more likely after the first dose than after the second. Mild Problems • Soreness or swelling where the shot was given (about 1 out of 5 children and up to 1 out of 3 adolescents and adults) • Fever (1 person out of 10, or less) • Mild rash, up to a month after vaccination (1 person out of 25). It is possible for these people to infect other members of their household, but this is extremely rare. Moderate Problems • Seizure (jerking or staring) caused by fever (very rare). sroberts on DSKD5P82C1PROD with NOTICES Severe Problems • Pneumonia (very rare). Other serious problems, including severe brain reactions and low blood count, have been reported after chickenpox vaccination. These happen so rarely experts cannot tell whether they are caused by the vaccine or not. If they are, it is extremely rare. Note: The first dose of MMRV vaccine has been associated with rash and higher rates of fever than MMR and varicella vaccines given separately. Rash has been reported in about 1 person in 20 and fever in about 1 person in 5. Seizures caused by a fever are also reported more often after MMRV. These usually occur 5–12 days after the first dose. VerDate Mar<15>2010 16:52 Aug 10, 2010 Jkt 220001 5. What if there is a severe or moderate reaction? Proposed MMRV Vaccine Information Statement What should I look for? Measles, Mumps, Rubella & Varicella (MMRV) Vaccine: What You Need To Know Any unusual condition, such as a high fever or behavior changes. Signs of a severe allergic reaction can include difficulty breathing, hoarseness or wheezing, hives, paleness, weakness, a fast heart beat or dizziness. What should I do? • Call a doctor, or get the person to a doctor right away. • Tell the doctor what happened, the date and time it happened, and when the vaccination was given. • Ask your provider to report the reaction by filing a Vaccine Adverse Event Reporting System (VAERS) form. Or you can file this report through the VAERS Web site at https:// w.vaers.hhs.gov, or by calling 1–800– 822–7967. VAERS does not provide medical advice. 6. The National Vaccine Injury Compensation Program The National Vaccine Injury Compensation Program (VICP) was created in 1986. Persons who believe they may have been injured by a vaccine may file a claim with VICP by calling 1–800–338– 2382 or visiting their Web site at https://www.hrsa.gov/ vaccinecompensation. 7. How can I learn more? • Ask your provider. They can give you the vaccine package insert or suggest other sources of information. • Call your local or state health department. • Contact the Centers for Disease Control and Prevention (CDC): —Call 1–800–232–4636 (1–800–CDC– INFO) —Visit CDC’s Web site at https:// www.cdc.gov/vaccines Department of Health and Human Services Centers for Disease Control and Prevention Vaccine Information Statement Varicella Vaccine (00/00/0000) (Proposed) 42 U.S.C. 300aa–26 * * * * * PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 1. Measles, Mumps, Rubella, and Varicella Measles, Mumps, Rubella, and Varicella (chickenpox) can be serious diseases: Measles • Causes rash, cough, runny nose, eye irritation, fever. • Can lead to ear infection, pneumonia, seizures (jerking and staring), brain damage, and death. Mumps • Causes fever, headache, swollen glands. • Can lead to deafness, meningitis (infection of the brain and spinal cord covering), infection of the pancreas, painful swelling of the testicles or ovaries, and rarely sterility or death. Rubella (German Measles) • Causes rash and mild fever; and can cause arthritis (mostly in women). • If a woman gets rubella while she is pregnant, she could have a miscarriage or her baby could be born with serious birth defects. Varicella (Chickenpox) • Causes rash, itching, fever, tiredness. • Can lead to severe skin infection, scars, pneumonia, brain amage, or death. • Can re-emerge years later as a painful rash called shingles. These diseases can spread from person to person through the air. Varicella can also be spread through contact with fluid from chickenpox blisters. Before vaccines, these diseases were very widespread in the United States. 2. MMRV Vaccine MMRV vaccine may be given to children from 1 through 12 years old to protect them from these four diseases. Two doses of MMRV vaccine are recommended: —The first dose at 12 through 15 months of age —The second dose at 4 through 6 years of age These are recommended ages. But children can get the second dose up through 12 years as long as it is at least 3 months after the first dose. Children may also get these vaccines as 2 separate shots: MMR (measles, mumps and rubella) and varicella. E:\FR\FM\11AUN1.SGM 11AUN1 Federal Register / Vol. 75, No. 154 / Wednesday, August 11, 2010 / Notices sroberts on DSKD5P82C1PROD with NOTICES 1 Shot (MMRV) or 2 Shots (MMR & Varicella)? • Both options give the same protection. • Fewer injections with MMRV. • MMRV has been associated with more fevers and fever-related seizures than MMR and varicella vaccines given separately (first dose only). Unless you specifically request otherwise, CDC recommends separate MMR and varicella vaccines for the first dose and MMRV vaccine for the second dose. Your health-care provider can give you more information, including the Vaccine Information Statements for MMR and Varicella vaccines. Anyone 13 or older who needs protection from these diseases should get MMR and varicella vaccines separately. MMRV may be given at the same time as other vaccines. 3. Some Children Should Not Get MMRV Vaccine or Should Wait Children should not get MMRV vaccine if they: • Have ever had a life-threatening allergic reaction to a previous dose of MMRV vaccine, or to either MMR or varicella vaccine • Have ever had a life-threatening allergic reaction to any component of the vaccine, including gelatin or the antibiotic neomycin. Tell the doctor if your child has any severe allergies. • Have HIV/AIDS, or another disease that affects the immune system • Are being treated with drugs that affect the immune system, such as high doses of steroids by mouth, for 2 weeks or longer • Have any kind of cancer • Are being treated for cancer with radiation or drugs Check with your doctor if the child: • Has a history of seizures, or has a parent, brother or sister with a history of seizures • Has a parent, brother or sister with a history of immune system problems • Has ever had a low platelet count, or another blood disorder • Recently had a transfusion or received other blood products • Might be pregnant Children who are moderately or severely ill at the time the shot is scheduled should usually wait until they recover before getting MMRV vaccine. Ask your provider for more information. 4. What are the risks from MMRV vaccine? A vaccine, like any medicine, is capable of causing serious problems, VerDate Mar<15>2010 16:52 Aug 10, 2010 Jkt 220001 such as severe allergic reactions. The risk of MMRV vaccine causing serious harm, or death, is extremely small. Getting MMRV vaccine is much safer than getting any of these four diseases. Most children who get MMRV vaccine do not have any problems with it. Mild Problems • Fever (about 1 child out of 5) • Mild rash (about 1 child out of 20) • Swelling of glands in the cheeks or neck (rare) If these problems occur, it is usually within 5–12 days after the first dose. They occur less often after the second dose. Moderate Problems • Seizure caused by fever (about 1 child in 1,250). These seizures usually occur 5–12 days after the first dose. They occur less often when MMR and varicella vaccines are given together as separate injections (about 1 child in 2,500), and rarely after a 2nd dose of MMRV. • Temporary low platelet count, which can cause a bleeding disorder (about 1 child out of 40,000) Severe Problems (Very Rare) 48719 VAERS does not provide medical advice. 6. The National Vaccine Injury Compensation Program The National Vaccine Injury Compensation Program (VICP) was created in 1986. Persons who believe they may have been injured by a vaccine may file a claim with VICP by calling 1–800–338– 2382 or visiting their Web site at https://www.hrsa.gov/ vaccinecompensation. 7. How can I learn more? • Ask your provider. They can give you the vaccine package insert or suggest other sources of information. • Call your local or state health department. • Contact the Centers for Disease Control and Prevention (CDC): —Call 1–800–232–4636 (1–800–CDC– INFO) —Visit CDC’s Web site at https:// www.cdc.gov/vaccines. Department of Health and Human Services, Centers for Disease Control and Prevention, Vaccine Information Statement, MMRV Vaccine, (00/00/0000) (Proposed) 42 U.S.C. 300aa–26. * * * * * Several severe problems have been reported following MMR vaccine, and might also occur after MMRV. These include severe allergic reactions (fewer than 4 per million), and problems such as: —Deafness —Long-term seizures, coma, lowered consciousness —Permanent brain damage Because these problems occur so rarely, we can’t be sure whether they are caused by the vaccine or not. Dated: August 3, 2010. Tanja Popovic, Deputy Associate Director for Science, Centers for Disease Control and Prevention. 5. What if there is a severe reaction? DEPARTMENT OF HOMELAND SECURITY [FR Doc. 2010–19785 Filed 8–10–10; 8:45 am] BILLING CODE 4163–18–P What should I look for? Any unusual condition, such as a high fever or behavior changes. Signs of a severe allergic reaction can include difficulty breathing, hoarseness or wheezing, hives, paleness, weakness, a fast heart beat or dizziness. What should I do? • Call a doctor, or get the person to a doctor right away. • Tell the doctor what happened, the date and time it happened, and when the vaccination was given. • Ask your provider to report the reaction by filing a Vaccine Adverse Event Reporting System (VAERS) form. Or you can file this report through the VAERS Web site at https:// www.vaers.hhs.gov, or by calling 1–800– 822–7967. PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 Federal Emergency Management Agency [Internal Agency Docket No. FEMA–1923– DR; Docket ID FEMA–2010–0002] Wyoming; Amendment No. 1 to Notice of a Major Disaster Declaration Federal Emergency Management Agency, DHS. ACTION: Notice. AGENCY: This notice amends the notice of a major disaster declaration for the State of Wyoming (FEMA–1923–DR), dated July 14, 2010, and related determinations. SUMMARY: DATES: Effective Date: August 4, 2010. FOR FURTHER INFORMATION CONTACT: Peggy Miller, Recovery Directorate, E:\FR\FM\11AUN1.SGM 11AUN1

Agencies

[Federal Register Volume 75, Number 154 (Wednesday, August 11, 2010)]
[Notices]
[Pages 48715-48719]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-19785]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Proposed Vaccine Information Materials for Measles, Mumps, 
Rubella, and Varicella Vaccines

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: Under the National Childhood Vaccine Injury Act (NCVIA) (42 
U.S.C. 300aa-26), the CDC must develop vaccine information materials 
that all health care providers are required to give to patients/parents 
prior to administration of specific vaccines. CDC seeks written comment 
on proposed new vaccine information materials for measles, mumps 
rubella (MMR); varicella, and measles, mumps, rubella; and varicella 
(MMRV).

DATES: Written comments are invited and must be received on or before 
October 12, 2010.

ADDRESSES: Written comments should be addressed to Anne Schuchat, M.D., 
Director, National Center for Immunization and Respiratory Diseases, 
Centers for Disease Control and Prevention, Mailstop E-05, 1600 Clifton 
Road, NE., Atlanta, Georgia 30333.

FOR FURTHER INFORMATION CONTACT: Skip Wolfe, National Center for 
Immunization and Respiratory Diseases, Centers for Disease Control and 
Prevention, Mailstop E-52, 1600 Clifton Road, NE., Atlanta, Georgia 
30333, telephone (404) 639-8809.

SUPPLEMENTARY INFORMATION: The National Childhood Vaccine Injury Act of 
1986 (Pub L. 99-660), as amended by section 708 of Public Law 103-183, 
added section 2126 to the Public Health Service Act. Section 2126, 
codified at 42 U.S.C. 300aa-26, requires the Secretary of Health and 
Human Services to develop and disseminate vaccine information materials 
for distribution by all health care providers in the United States to 
any patient (or to the parent or legal representative in the case of a 
child) receiving vaccines covered under the National Vaccine Injury 
Compensation Program.
    Development and revision of the vaccine information materials, also 
known as Vaccine Information Statements (VIS), have been delegated by 
the Secretary to the Centers for Disease Control and Prevention (CDC). 
Section 2126 requires that the materials be developed, or revised, 
after notice to the public, with a 60-day comment

[[Page 48716]]

period, and in consultation with the Advisory Commission on Childhood 
Vaccines, appropriate health care provider and parent organizations, 
and the Food and Drug Administration. The law also requires that the 
information contained in the materials be based on available data and 
information, be presented in understandable terms, and include:
    (1) A concise description of the benefits of the vaccine,
    (2) A concise description of the risks associated with the vaccine,
    (3) A statement of the availability of the National Vaccine Injury 
Compensation Program, and
    (4) Such other relevant information as may be determined by the 
Secretary.
    The vaccines initially covered under the National Vaccine Injury 
Compensation Program were diphtheria, tetanus, pertussis, measles, 
mumps, rubella and poliomyelitis vaccines. Since April 15, 1992, any 
health care provider in the United States who intends to administer one 
of these covered vaccines is required to provide copies of the relevant 
vaccine information materials prior to administration of any of these 
vaccines. Since then, the following vaccines have been added to the 
National Vaccine Injury Compensation Program, requiring use of vaccine 
information materials for them as well: Hepatitis B, haemophilus 
influenzae type b (Hib), varicella (chickenpox), pneumococcal 
conjugate, rotavirus, hepatitis A, meningococcal, human papillomavirus 
(HPV), and trivalent influenza vaccines. Instructions for use of the 
vaccine information materials and copies of the materials can be found 
on the CDC Web site at: https://www.cdc.gov/vaccines/pubs/VIS/. In 
addition, single camera-ready copies may be available from State health 
departments. A list of State health department contacts for obtaining 
copies of these materials is included in a December 17, 1999 Federal 
Register notice (64 FR 70914).

Proposed Measles, Mumps, Rubella (MMR); Varicella; and Measles, Mumps, 
Rubella & Varicella (MMRV) Vaccine Information Materials

    On May 7, 2010 the Advisory Committee on Immunization Practices 
(ACIP) published recommendations on the use of combined Measles, Mumps, 
Rubella and Varicella (MMRV) vaccine. Because CDC/ACIP are now 
expressing a preference for use of MMRV vaccine (over MMR + V given 
separately) in some circumstances and the two separate vaccines in 
other circumstances, CDC is proposing publication of unique vaccine 
information materials for MMRV vaccine, which are included in this 
notice. In addition, CDC is proposing updated versions of the separate 
MMR and varicella vaccine information materials, containing information 
about MMRV vaccine.

Development of Vaccine Information Materials

    The vaccine information materials referenced in this notice are 
being developed in consultation with the Advisory Commission on 
Childhood Vaccines, the Food and Drug Administration, and parent and 
health care provider groups.
    In addition, we invite written comment on the proposed vaccine 
information materials that follow, entitled ``Measles, Mumps, Rubella 
(MMR) Vaccine: What You Need to Know;'' ``Varicella Vaccine: What You 
Need to Know;'' and ``Measles, Mumps, Rubella and Varicella (MMRV) 
Vaccine: What You Need to Know.'' Comments submitted will be considered 
in finalizing these materials. When the final materials are published 
in the Federal Register, the notice will include an effective date for 
their mandatory use.
    We also propose to revise the June 9, 2010 Instructions for the Use 
of Vaccine Information Statements to include a reference to these 
vaccine information materials.
* * * * *

Proposed MMR Vaccine Information Statement

Measles, Mumps and Rubella (MMR) Vaccines: What You Need to Know
1. Why get vaccinated?
    Measles, mumps, and rubella are serious diseases.
Measles
     Measles virus causes rash, cough, runny nose, eye 
irritation, and fever.
     It can lead to ear infection, pneumonia, seizures (jerking 
and staring), brain damage, and death.
Mumps
     Mumps virus causes fever, headache, and swollen glands.
     It can lead to deafness, meningitis (infection of the 
brain and spinal cord covering), painful swelling of the testicles or 
ovaries, and rarely sterility or death.
Rubella (German Measles)
     Rubella virus causes rash, mild fever, and arthritis 
(mostly in women).
     If a woman gets rubella while she is pregnant, she could 
have a miscarriage or her baby could be born with serious birth 
defects.
    You or your child could catch these diseases by being around 
someone who has them. They spread from person to person through the 
air.
    Measles, mumps, and rubella (MMR) vaccine can prevent these 
diseases. Most children who get their MMR shots will not get these 
diseases. Many more children would get them if we stopped vaccinating.
2. Who should get MMR vaccine and when?
    Children should get 2 doses of MMR vaccine:

--The first at 12-15 months of age
--and the second at 4-6 years of age.

    These are the recommended ages. But children can get the second 
dose at any age, as long as it is at least 28 days after the first 
dose.
    Some adults should also get MMR vaccine: Generally, anyone 18 years 
of age or older who was born after 1956 should get at least one dose of 
MMR vaccine, unless they can show that they have had either the 
vaccines or the diseases.
    Ask your provider for more information.
    MMR vaccine may be given at the same time as other vaccines.

    Note:  Children 12 years of age and younger can receive a 
``combination'' vaccine called MMRV, which contains both MMR and 
varicella (chickenpox) vaccines. See the MMRV Vaccine Information 
Statement for more information.

3. Some People Should Not Get MMR Vaccine or Should Wait
     People should not get MMR vaccine who have ever had a 
life-threatening allergic reaction to gelatin, the antibiotic neomycin, 
or to a previous dose of MMR vaccine.
     People who are moderately or severely ill at the time the 
shot is scheduled should usually wait until they recover before getting 
MMR vaccine.
     Pregnant women should wait to get MMR vaccine until after 
they have given birth. Women should avoid getting pregnant for 4 weeks 
after getting MMR vaccine.
     Some people should check with their doctor about whether 
they should get MMR vaccine, including anyone who:

--Has HIV/AIDS, or another disease that affects the immune system.
--Is being treated with drugs that affect the immune system, such as 
steroids, for 2 weeks or longer.
--Has any kind of cancer.

[[Page 48717]]

--Is taking cancer treatment with x-rays or drugs.
--Has ever had a low platelet count (a blood disorder).

     People who recently had a transfusion or were given other 
blood products should ask their doctor when they may get MMR vaccine.
    Ask your provider for more information.
4. What are the risks from MMR vaccine?
    A vaccine, like any medicine, is capable of causing serious 
problems, such as severe allergic reactions. The risk of MMR vaccine 
causing serious harm, or death, is extremely small.
    Getting MMR vaccine is much safer than getting any of these three 
diseases.
    Most people who get MMR vaccine do not have any problems with it.
Mild Problems
     Fever (up to 1 person out of 6)
     Mild rash (about 1 person out of 20)
     Swelling of glands in the cheeks or neck (rare)
    If these problems occur, it is usually within 7-12 days after the 
shot. They occur less often after the second dose.
Moderate Problems
     Seizure (jerking or staring) caused by fever (about 1 out 
of 3,000 doses)
     Temporary pain and stiffness in the joints, mostly in 
teenage or adult women (up to 1 out of 4)
     Temporary low platelet count, which can cause a bleeding 
disorder (about 1 out of 30,000 doses)
Severe Problems (Very Rare)
     Serious allergic reaction (less than 1 out of a million 
doses).
     Several other severe problems have been known to occur 
after a child gets MMR vaccine. But this happens so rarely, experts 
cannot be sure whether they are caused by the vaccine or not. These 
include:

--Deafness,
--Long-term seizures, coma, or lowered consciousness,
--Permanent brain damage.

    Note: The first dose of MMRV vaccine has been associated with 
rash and higher rates of fever than MMR and varicella vaccines given 
separately. Rash has been reported in about 1 person in 20 and fever 
in about 1 person in 5.
    Seizures caused by a fever are also reported more often after 
MMRV. These usually occur 5-12 days after the first dose.

5. What if there is a severe or moderate reaction?
What should I look for?
    Any unusual condition, such as a high fever or behavior changes. 
Signs of a severe allergic reaction can include difficulty breathing, 
hoarseness or wheezing, hives, paleness, weakness, a fast heart beat or 
dizziness.
What should I do?
     Call a doctor, or get the person to a doctor right away.
     Tell the doctor what happened, the date and time it 
happened, and when the vaccination was given.
     Ask your provider to report the reaction by filing a 
Vaccine Adverse Event Reporting System (VAERS) form. Or you can file 
this report through the VAERS Web site at https://www.vaers.hhs.gov, or 
by calling 1-800-822-7967.
    VAERS does not provide medical advice.
6. The National Vaccine Injury Compensation Program
    The National Vaccine Injury Compensation Program (VICP) was created 
in 1986.
    Persons who believe they may have been injured by a vaccine may 
file a claim with VICP by calling 1-800-338-2382 or visiting their Web 
site at https://www.hrsa.gov/vaccinecompensation vaccinecompensation.
7. How can I learn more?
     Ask your provider. They can give you the vaccine package 
insert or suggest other sources of information.
     Call your local or state health department.
     Contact the Centers for Disease Control and Prevention 
(CDC):

--Call 1-800-232-4636 (1-800-CDC-INFO)
--Visit CDC's Web site at https://www.cdc.gov/vaccines
Department of Health and Human Services
Centers for Disease Control and Prevention
Vaccine Information Statement
MMR Vaccine
(00/00/0000) (Proposed)
42 U.S.C. 300aa-26
* * * * *

Proposed Varicella (Chickenpox) Vaccine Information Statement

Chickenpox Vaccine: What You Need to Know
1. Why get vaccinated?
    Chickenpox (also called varicella) is a common childhood disease. 
It is usually mild, but it can be serious, especially in young infants 
and adults.
     It causes a rash, itching, fever, and tiredness.
     It can lead to severe skin infection, scars, pneumonia, 
brain damage, or death.
     The chickenpox virus can be spread from person to person 
through the air, or by contact with fluid from chickenpox blisters.
     A person who has had chickenpox can get a painful rash 
called shingles years later.
     Before the vaccine, about 11,000 people were hospitalized 
for chickenpox each year in the United States.
     Before the vaccine, about 100 people died each year as a 
result of chickenpox in the United States.
    Chickenpox vaccine can prevent chickenpox.
    Most people who get chickenpox vaccine will not get chickenpox. But 
if someone who has been vaccinated does get chickenpox, it is usually 
very mild. They will have fewer blisters, are less likely to have a 
fever, and will recover faster.
2. Who should get chickenpox vaccine and when?
Routine
    Children who have never had chickenpox should get 2 doses of 
chickenpox vaccine at these ages:

1st Dose: 12-15 months of age
2nd Dose: 4-6 years of age (may be given earlier, if at least 3 months 
after the 1st dose)

    People 13 years of age and older (who have never had chickenpox or 
received chickenpox vaccine) should get two doses at least 28 days 
apart.
Catch-Up
    Anyone who is not fully vaccinated, and never had chickenpox, 
should receive one or two doses of chickenpox vaccine. The timing of 
these doses depends on the person's age. Ask your provider.
    Chickenpox vaccine may be given at the same time as other vaccines.

    Note:  Children 12 years of age and younger can receive a 
``combination'' vaccine called MMRV, which contains both MMR and 
varicella (chickenpox) vaccines. See the MMRV Vaccine Information 
Statement for more information.

3. Some People Should Not Get Chickenpox Vaccine or Should Wait
     People should not get chickenpox vaccine if they have ever 
had a life-threatening allergic reaction to a previous dose of 
chickenpox vaccine or to gelatin or the antibiotic neomycin.
     People who are moderately or severely ill at the time the 
shot is scheduled should usually wait until they recover before getting 
chickenpox vaccine.
     Pregnant women should wait to get chickenpox vaccine until 
after they have

[[Page 48718]]

given birth. Women should not get pregnant for 1 month after getting 
chickenpox vaccine.
     Some people should check with their doctor about whether 
they should get chickenpox vaccine, including anyone who:

--Has HIV/AIDS or another disease that affects the immune system
--Is being treated with drugs that affect the immune system, such as 
steroids, for 2 weeks or longer
--Has any kind of cancer
--Is getting cancer treatment with radiation or drugs

     People who recently had a transfusion or were given other 
blood products should ask their doctor when they may get chickenpox 
vaccine.
    Ask your provider for more information.
4. What are the risks from chickenpox vaccine?
    A vaccine, like any medicine, is capable of causing serious 
problems, such as severe allergic reactions. The risk of chickenpox 
vaccine causing serious harm, or death, is extremely small.
    Getting chickenpox vaccine is much safer than getting chickenpox 
disease. Most people who get chickenpox vaccine do not have any 
problems with it. Reactions are usually more likely after the first 
dose than after the second.
Mild Problems
     Soreness or swelling where the shot was given (about 1 out 
of 5 children and up to 1 out of 3 adolescents and adults)
     Fever (1 person out of 10, or less)
     Mild rash, up to a month after vaccination (1 person out 
of 25). It is possible for these people to infect other members of 
their household, but this is extremely rare.
Moderate Problems
     Seizure (jerking or staring) caused by fever (very rare).
Severe Problems
     Pneumonia (very rare).
    Other serious problems, including severe brain reactions and low 
blood count, have been reported after chickenpox vaccination. These 
happen so rarely experts cannot tell whether they are caused by the 
vaccine or not. If they are, it is extremely rare.

    Note:  The first dose of MMRV vaccine has been associated with 
rash and higher rates of fever than MMR and varicella vaccines given 
separately. Rash has been reported in about 1 person in 20 and fever 
in about 1 person in 5.
    Seizures caused by a fever are also reported more often after 
MMRV. These usually occur 5-12 days after the first dose.

5. What if there is a severe or moderate reaction?
What should I look for?
    Any unusual condition, such as a high fever or behavior changes. 
Signs of a severe allergic reaction can include difficulty breathing, 
hoarseness or wheezing, hives, paleness, weakness, a fast heart beat or 
dizziness.
What should I do?
     Call a doctor, or get the person to a doctor right away.
     Tell the doctor what happened, the date and time it 
happened, and when the vaccination was given.
     Ask your provider to report the reaction by filing a 
Vaccine Adverse Event Reporting System (VAERS) form. Or you can file 
this report through the VAERS Web site at https://w.vaers.hhs.gov, or by 
calling 1-800-822-7967.
    VAERS does not provide medical advice.
6. The National Vaccine Injury Compensation Program
    The National Vaccine Injury Compensation Program (VICP) was created 
in 1986.
    Persons who believe they may have been injured by a vaccine may 
file a claim with VICP by calling 1-800-338-2382 or visiting their Web 
site at https://www.hrsa.gov/vaccinecompensation vaccinecompensation.
7. How can I learn more?
     Ask your provider. They can give you the vaccine package 
insert or suggest other sources of information.
     Call your local or state health department.
     Contact the Centers for Disease Control and Prevention 
(CDC):
--Call 1-800-232-4636 (1-800-CDC-INFO)
--Visit CDC's Web site at https://www.cdc.gov/vaccines
Department of Health and Human Services
Centers for Disease Control and Prevention
Vaccine Information Statement
Varicella Vaccine
(00/00/0000) (Proposed)
42 U.S.C. 300aa-26
* * * * *

Proposed MMRV Vaccine Information Statement

Measles, Mumps, Rubella & Varicella (MMRV) Vaccine: What You Need To 
Know
1. Measles, Mumps, Rubella, and Varicella
    Measles, Mumps, Rubella, and Varicella (chickenpox) can be serious 
diseases:
Measles
     Causes rash, cough, runny nose, eye irritation, fever.
     Can lead to ear infection, pneumonia, seizures (jerking 
and staring), brain damage, and death.
Mumps
     Causes fever, headache, swollen glands.
     Can lead to deafness, meningitis (infection of the brain 
and spinal cord covering), infection of the pancreas, painful swelling 
of the testicles or ovaries, and rarely sterility or death.
Rubella (German Measles)
     Causes rash and mild fever; and can cause arthritis 
(mostly in women).
     If a woman gets rubella while she is pregnant, she could 
have a miscarriage or her baby could be born with serious birth 
defects.
Varicella (Chickenpox)
     Causes rash, itching, fever, tiredness.
     Can lead to severe skin infection, scars, pneumonia, brain 
amage, or death.
     Can re-emerge years later as a painful rash called 
shingles.
    These diseases can spread from person to person through the air. 
Varicella can also be spread through contact with fluid from chickenpox 
blisters.
    Before vaccines, these diseases were very widespread in the United 
States.
2. MMRV Vaccine
    MMRV vaccine may be given to children from 1 through 12 years old 
to protect them from these four diseases.
    Two doses of MMRV vaccine are recommended:

--The first dose at 12 through 15 months of age
--The second dose at 4 through 6 years of age

    These are recommended ages. But children can get the second dose up 
through 12 years as long as it is at least 3 months after the first 
dose.
    Children may also get these vaccines as 2 separate shots: MMR 
(measles, mumps and rubella) and varicella.

[[Page 48719]]

1 Shot (MMRV) or 2 Shots (MMR & Varicella)?

     Both options give the same protection.
     Fewer injections with MMRV.
     MMRV has been associated with more fevers and fever-
related seizures than MMR and varicella vaccines given separately 
(first dose only).
    Unless you specifically request otherwise, CDC recommends separate 
MMR and varicella vaccines for the first dose and MMRV vaccine for the 
second dose.
    Your health-care provider can give you more information, including 
the Vaccine Information Statements for MMR and Varicella vaccines.
    Anyone 13 or older who needs protection from these diseases should 
get MMR and varicella vaccines separately.
    MMRV may be given at the same time as other vaccines.
3. Some Children Should Not Get MMRV Vaccine or Should Wait
    Children should not get MMRV vaccine if they:
     Have ever had a life-threatening allergic reaction to a 
previous dose of MMRV vaccine, or to either MMR or varicella vaccine
     Have ever had a life-threatening allergic reaction to any 
component of the vaccine, including gelatin or the antibiotic neomycin. 
Tell the doctor if your child has any severe allergies.
     Have HIV/AIDS, or another disease that affects the immune 
system
     Are being treated with drugs that affect the immune 
system, such as high doses of steroids by mouth, for 2 weeks or longer
     Have any kind of cancer
     Are being treated for cancer with radiation or drugs
    Check with your doctor if the child:
     Has a history of seizures, or has a parent, brother or 
sister with a history of seizures
     Has a parent, brother or sister with a history of immune 
system problems
     Has ever had a low platelet count, or another blood 
disorder
     Recently had a transfusion or received other blood 
products
     Might be pregnant
    Children who are moderately or severely ill at the time the shot is 
scheduled should usually wait until they recover before getting MMRV 
vaccine.
    Ask your provider for more information.
4. What are the risks from MMRV vaccine?
    A vaccine, like any medicine, is capable of causing serious 
problems, such as severe allergic reactions. The risk of MMRV vaccine 
causing serious harm, or death, is extremely small.
    Getting MMRV vaccine is much safer than getting any of these four 
diseases.
    Most children who get MMRV vaccine do not have any problems with 
it.
Mild Problems
     Fever (about 1 child out of 5)
     Mild rash (about 1 child out of 20)
     Swelling of glands in the cheeks or neck (rare)
    If these problems occur, it is usually within 5-12 days after the 
first dose. They occur less often after the second dose.
Moderate Problems
     Seizure caused by fever (about 1 child in 1,250). These 
seizures usually occur 5-12 days after the first dose. They occur less 
often when MMR and varicella vaccines are given together as separate 
injections (about 1 child in 2,500), and rarely after a 2nd dose of 
MMRV.
     Temporary low platelet count, which can cause a bleeding 
disorder (about 1 child out of 40,000)
Severe Problems (Very Rare)
    Several severe problems have been reported following MMR vaccine, 
and might also occur after MMRV. These include severe allergic 
reactions (fewer than 4 per million), and problems such as:

--Deafness
--Long-term seizures, coma, lowered consciousness
--Permanent brain damage

    Because these problems occur so rarely, we can't be sure whether 
they are caused by the vaccine or not.
5. What if there is a severe reaction?
What should I look for?
    Any unusual condition, such as a high fever or behavior changes. 
Signs of a severe allergic reaction can include difficulty breathing, 
hoarseness or wheezing, hives, paleness, weakness, a fast heart beat or 
dizziness.
What should I do?
     Call a doctor, or get the person to a doctor right away.
     Tell the doctor what happened, the date and time it 
happened, and when the vaccination was given.
     Ask your provider to report the reaction by filing a 
Vaccine Adverse Event Reporting System (VAERS) form. Or you can file 
this report through the VAERS Web site at https://www.vaers.hhs.gov, or 
by calling 1-800-822-7967.
    VAERS does not provide medical advice.
6. The National Vaccine Injury Compensation Program
    The National Vaccine Injury Compensation Program (VICP) was created 
in 1986.
    Persons who believe they may have been injured by a vaccine may 
file a claim with VICP by calling 1-800-338-2382 or visiting their Web 
site at https://www.hrsa.gov/vaccinecompensation vaccinecompensation.
7. How can I learn more?
     Ask your provider. They can give you the vaccine package 
insert or suggest other sources of information.
     Call your local or state health department.
     Contact the Centers for Disease Control and Prevention 
(CDC):

--Call 1-800-232-4636 (1-800-CDC-INFO)
--Visit CDC's Web site at https://www.cdc.gov/vaccines.
Department of Health and Human Services,
Centers for Disease Control and Prevention,
Vaccine Information Statement,
MMRV Vaccine,
(00/00/0000) (Proposed)
42 U.S.C. 300aa-26.
* * * * *

    Dated: August 3, 2010.
Tanja Popovic,
Deputy Associate Director for Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2010-19785 Filed 8-10-10; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.